2.72
price up icon1.12%   0.03
after-market Dopo l'orario di chiusura: 2.73 0.010 +0.37%
loading

Jasper Therapeutics Inc Azioni (JSPR) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - -
Operating Expenses
13.77%
21.80
25.29 19.89 15.99 15.07
Depreciation and Amortization
13.88%
0.279
0.245 0.50 0.30 0.288
Operating Income/Loss
13.77%
-21.80
-25.29 -19.89 -15.99 -15.07
Nonoperating Income/Loss
41.80%
0.561
0.964 1.252 1.41 1.344
Income/Loss From Continuing Operations Before Tax
12.66%
-21.24
-24.32 -18.64 -14.58 -13.73
Income/Loss From Continuing Operations After Tax
12.66%
-21.24
-24.32 -18.64 -14.58 -13.73
Net Income/Loss
12.66%
-21.24
-24.32 -18.64 -14.58 -13.73
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
10,462%
15.02
0.1422 15.00 14.99 13.33
Diluted Average Shares
10,462%
15.02
0.1422 15.00 14.99 13.33
Basic Earnings Per Share
14.02%
-1.41
-1.64 -1.24 -0.97 -1.03
Diluted Earnings Per Share
14.02%
-1.41
-1.64 -1.24 -0.97 -1.03
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$86.64
price up icon 1.40%
$27.54
price up icon 0.58%
$25.98
price up icon 9.16%
$112.46
price up icon 8.66%
$145.10
price up icon 1.80%
biotechnology ONC
$341.80
price up icon 7.24%
Capitalizzazione:     |  Volume (24 ore):